Systematically understanding the immunity leading to CRPC progression

Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has become a standard treatment strategy for advanced PCa. Although a majority of patients initially respond to ADT well, most of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Zhiwei, Zhao, Weiling, Lin, Hui-Kuan, Zhou, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754164/
https://www.ncbi.nlm.nih.gov/pubmed/31504033
http://dx.doi.org/10.1371/journal.pcbi.1007344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754164/
https://www.ncbi.nlm.nih.gov/pubmed/31504033
http://dx.doi.org/10.1371/journal.pcbi.1007344

Ejemplares similares